Clinical Trials Logo

Migraine Disorders clinical trials

View clinical trials related to Migraine Disorders.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT03934086 No longer available - Migraine Clinical Trials

An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine

Start date: n/a
Phase:
Study type: Expanded Access

The purpose of this protocol is to allow subjects who completed any BHV3000 (rimegepant) clinical study to continue to have access to rimegepant while collecting ongoing safety data. (NOTE: ONLY FOR PATIENTS who participated in a previous BHV-3000/Rimegepant Clinical Trial in the past)

NCT ID: NCT03539393 No longer available - Migraine Clinical Trials

Expanded Access Program for Patients With Migraine

Start date: n/a
Phase:
Study type: Expanded Access

This expanded access program is designed to make fremanezumab available to patients with EM or CM who have successfully completed (per protocol) Teva-sponsored Study TV48125-CNS-30051 or TV48125-CNS-30068 ("prior studies") until fremanezumab becomes commercially available in their country.